Alternatives
Alternatives to Xeljanz XR 11 mg extended-release tablet
1 other presentations of Tofacitinib 11 mg extended-release tablet
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Tofacitinib), strength (11 mg) and dosage form (extended-release tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Xeljanz XR 11 mg extended-release tabletThis pageOral | Pfizer Laboratories | US FDA | 30 tablets, 30 tablets | Store XELJANZ tablets and XELJANZ XR at 20°C to 25°C (68°F to 77°F). Storage and Handling for XELJANZ Oral Solution Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (between 59°F and 86°F). Store in the original bottle and carton to protect from light. | On request | — | Available on request |
| Tofacitinib 11 mg extended-release tabletOral | — | US FDA | 30 tablets, 90 tablets | Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Xeljanz XR 11 mg extended-release tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.